跳至主要内容
临床试验/ACTRN12622001251718
ACTRN12622001251718尚未招募2 期

Efficacy of tadalafil therapy in women with refractory idiopathic detrusor overactivity.

Western Sydney Local Health District0 个研究点目标入组 25 人开始时间: 2022年9月19日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
Female

入选标准

  • Eligible patients are those with urodynamically proven idiopathic detrusor overactivity who have failed to respond significantly to all other medical treatments (including botulinum toxin injections) for their overactive bladder symptoms. Patients who had some benefit but intolerable side-effects from any of these treatments can also be enrolled.

排除标准

  • Age > 85 years
  • Pregnancy, lactation
  • Undiagnosed bleeding in patients with a uterus (use of PDE5 inhibitors in assisted reproduction can cause endometrial thickening)
  • Unstable angina, uncontrolled hypotension <90/50
  • Moderately severe cardiac failure or uncontrolled arrhythmias
  • Myocardial or cerebral infarction within six months
  • Concomitant use of nitrates
  • Previous NAION – non-arteritic anterior ischaemic optic neuropathy
  • Severe hepatic impairment
  • End-stage renal disease
  • Some medication and juices

研究者

相似试验